SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH -- Ignore unavailable to you. Want to Upgrade?

To: Len who wrote (850)1/13/1999 7:10:00 PM
From: bob s  Respond to of 998
 
Len-Presentation was today and I know of Murphy's hotline but I was hoping others could give their perspective to balance or confirm his viewpoint. Bob



To: Len who wrote (850)1/15/1999 5:32:00 PM
From: Henry Niman  Read Replies (2) | Respond to of 998
 
Michael Murphy was just on CNBC to talk about Biotechs. He indicated that the sector had over 200 products (in late stage? trials) and said that products were finally coming to market. He suggested investors target companies with products just coming to market and mentioned CEPH, CORR, LGND, and ISIP.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News